Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...

Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of ...

Ted Koppel and his wife, Grace Anne Dorney Koppel — who was told she only had a few years left to live after her 2001 COPD ...

Lung disease involving long-term poor airflow From Wikipedia, the free encyclopedia ...

Mucociliary dysfunction, chronic infections with advancing immunosenescence and pulmonary emphysema as seen in COPD may be just as relevant to ACOS. Possible drug targets include receptors of the ...

In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...

In the US, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease, or COPD. We're discussing a new treatment option that may help patients.